Hedge Fund and Insider Trading News: Crispin Odey, Pine River Capital Management, Alden Global Capital, True Arrow Capital Management, Theseus Pharmaceuticals, Inc. (THRX), Fastenal Co (FAST), and More

Page 2 of 2

Kraken Names Mark Jennings as New CEO of Its London Firm (Financial News)
Kraken’s London-based subsidiary Crypto Facilities has appointed former hedge fund manager Mark Jennings as its chief executive officer. Jennings, who previously worked as a chief operating officer of US-based quant hedge fund True Arrow Capital Management from January 2016 to October 2020, told Financial News he plans to boost the firm’s relationship with City hedge funds.

From Botany to Bridgewater: Behind the Numbers with Unlimited Funds’ Bob Elliott (MarketScale)
For a better perspective on the U.S. economy, looking behind the numbers for a proper understanding of where things stand is helpful. As Americans grapple with the shifting dynamics of its economy, a new narrative has emerged, challenging the collective understanding of where the economic heartbeat of our nation truly resides. People have grown accustomed to Silicon Valley and Wall Street as the standard bearers of growth and prosperity. Yet, more than two-thirds of large urban counties experienced population decline in 2021, seeking suburban and small metro counties. This shift signals the need for recalibration in our economic mindset, prompting a pivotal question.

Inside the Private Writings of Caroline Ellison, Star Witness in the FTX Case (The New York Times)
Three months before the cryptocurrency market imploded last year, Caroline Ellison, the 27-year-old chief executive of the crypto hedge fund Alameda Research, was racked with self-doubt. “I have been feeling pretty unhappy and overwhelmed with my job,” Ms. Ellison wrote in a Google document in February 2022. She added: “At the end of the day I can’t wait to go home and turn off my phone and have a drink and get away from it all.”

Wednesday 7/19 Insider Buying Report: FAST, GABC (Nasdaq.com)
On Monday, Fastenal’s , Michael J. Ancius, made a $28,765 buy of FAST, purchasing 500 shares at a cost of $57.53 each. Investors can buy FAST at a price even lower than Ancius did, with shares trading as low as $56.55 in trading on Wednesday which is 1.7% below Ancius’s purchase price. Fastenal is trading up about 0.9% on the day Wednesday. Before this latest buy, Ancius made one other purchase in the past year, buying $24,310 shares for a cost of $48.62 a piece. And at German American Bancorp, there was insider buying on Saturday, by Susan J. Ellspermann who bought 723 shares at a cost of $27.67 each, for a trade totaling $20,000. Before this latest buy, Ellspermann purchased GABC at 7 other times during the past year, for a total investment of $15,276 at an average of $37.34 per share. German American Bancorp Inc is trading up about 2.6% on the day Wednesday. So far Ellspermann is in the green, up about 4.7% on their purchase based on today’s trading high of $28.98.

$2M Bet On Molecular Templates? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying (Benzinga)
Theseus Pharmaceuticals: The Trade: Theseus Pharmaceuticals, Inc. (THRX) 10% owner James Tananbaum acquired a total of 700,000 shares an average price of $2.97. To acquire these shares, it cost around $2.08 million. The company’s other Directors also purchased the company’s shares. Molecular Templates: The Trade: Molecular Templates, Inc. (MTEM) 10% owner BB Biotech AG acquired a total of 4,255,319 shares at an average price of $0.47. The insider spent around $2 million.

Page 2 of 2